Literature DB >> 19531490

Phosphorylation-dependent autoinhibition of myosin light chain phosphatase accounts for Ca2+ sensitization force of smooth muscle contraction.

Alexander Khromov1, Nandini Choudhury, Andra S Stevenson, Avril V Somlyo, Masumi Eto.   

Abstract

The reversible regulation of myosin light chain phosphatase (MLCP) in response to agonist stimulation and cAMP/cGMP signals plays an important role in the regulation of smooth muscle (SM) tone. Here, we investigated the mechanism underlying the inhibition of MLCP induced by the phosphorylation of myosin phosphatase targeting subunit (MYPT1), a regulatory subunit of MLCP, at Thr-696 and Thr-853 using glutathione S-transferase (GST)-MYPT1 fragments having the inhibitory phosphorylation sites. GST-MYPT1 fragments, including only Thr-696 and only Thr-853, inhibited purified MLCP (IC(50) = 1.6 and 60 nm, respectively) when they were phosphorylated with RhoA-dependent kinase (ROCK). The activities of isolated catalytic subunits of type 1 and type 2A phosphatases (PP1 and PP2A) were insensitive to either fragment. Phospho-GST-MYPT1 fragments docked directly at the active site of MLCP, and this was blocked by a PP1/PP2A inhibitor microcystin (MC)-LR or by mutation of the active sites in PP1. GST-MYPT1 fragments induced a contraction of beta-escin-permeabilized ileum SM at constant pCa 6.3 (EC(50) = 2 microm), which was eliminated by Ala substitution of the fragment at Thr-696 or by ROCK inhibitors or 8Br-cGMP. GST-MYPT1-(697-880) was 5-times less potent than fragments including Thr-696. Relaxation induced by 8Br-cGMP was not affected by Ala substitution at Ser-695, a known phosphorylation site for protein kinase A/G. Thus, GST-MYPT1 fragments are phosphorylated by ROCK in permeabilized SM and mimic agonist-induced inhibition and cGMP-induced activation of MLCP. We propose a model in which MYPT1 phosphorylation at Thr-696 and Thr-853 causes an autoinhibition of MLCP that accounts for Ca(2+) sensitization of smooth muscle force.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19531490      PMCID: PMC2755881          DOI: 10.1074/jbc.M109.019729

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  Phosphoprotein inhibitors of protein phosphatase-1.

Authors:  Masumi Eto; Craig Leach; Nikolaos A Tountas; David L Brautigan
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

2.  Unzipping the role of myosin light chain phosphatase in smooth muscle cell relaxation.

Authors:  Qi Quan Huang; Steven A Fisher; Frank V Brozovich
Journal:  J Biol Chem       Date:  2003-10-06       Impact factor: 5.157

3.  Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle.

Authors:  Yu Wang; Kazuaki Yoshioka; Mohammed Ali Azam; Noriko Takuwa; Sotaro Sakurada; Yuji Kayaba; Naotoshi Sugimoto; Isao Inoki; Takaharu Kimura; Tomoyuki Kuwaki; Yoh Takuwa
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

4.  Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension.

Authors:  Christophe Guilluy; Vincent Sauzeau; Malvyne Rolli-Derkinderen; Patrice Guérin; Christine Sagan; Pierre Pacaud; Gervaise Loirand
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

5.  Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells.

Authors:  Andrea Murányi; Dmitry Derkach; Ferenc Erdodi; Andrea Kiss; Masaaki Ito; David J Hartshorne
Journal:  FEBS Lett       Date:  2005-11-09       Impact factor: 4.124

6.  Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle.

Authors:  George J Dimopoulos; Shingo Semba; Kazuyo Kitazawa; Masumi Eto; Toshio Kitazawa
Journal:  Circ Res       Date:  2006-12-07       Impact factor: 17.367

7.  Assembly of MYPT1 with protein phosphatase-1 in fibroblasts redirects localization and reorganizes the actin cytoskeleton.

Authors:  Masumi Eto; Jason A Kirkbride; David L Brautigan
Journal:  Cell Motil Cytoskeleton       Date:  2005-10

8.  Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits.

Authors:  Masumi Eto; Toshio Kitazawa; David L Brautigan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

9.  Actions downstream of cyclic GMP/protein kinase G can reverse protein kinase C-mediated phosphorylation of CPI-17 and Ca²⁺ sensitization in smooth muscle.

Authors:  Johan Bonnevier; Anders Arner
Journal:  J Biol Chem       Date:  2004-04-29       Impact factor: 5.157

10.  Structural basis of protein phosphatase 1 regulation.

Authors:  Mohammed Terrak; Frederic Kerff; Knut Langsetmo; Terence Tao; Roberto Dominguez
Journal:  Nature       Date:  2004-05-26       Impact factor: 49.962

View more
  57 in total

1.  Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells.

Authors:  Jee In Kim; Mark Urban; Garbo D Young; Masumi Eto
Journal:  Am J Physiol Cell Physiol       Date:  2012-04-25       Impact factor: 4.249

2.  Mechanisms underlying potentiation of endothelin-1-induced myofilament Ca(2+) sensitization after subarachnoid hemorrhage.

Authors:  Yuichiro Kikkawa; Satoshi Matsuo; Katsuharu Kameda; Mayumi Hirano; Akira Nakamizo; Tomio Sasaki; Katsuya Hirano
Journal:  J Cereb Blood Flow Metab       Date:  2011-09-28       Impact factor: 6.200

3.  Effect of elevated intracellular cAMP levels on actomyosin contraction in bovine trabecular meshwork cells.

Authors:  Charanya Ramachandran; Rajkumar V Patil; Najam A Sharif; Sangly P Srinivas
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-18       Impact factor: 4.799

Review 4.  Myosin light chain kinase and the role of myosin light chain phosphorylation in skeletal muscle.

Authors:  James T Stull; Kristine E Kamm; Rene Vandenboom
Journal:  Arch Biochem Biophys       Date:  2011-02-01       Impact factor: 4.013

5.  Pressure-dependent contribution of Rho kinase-mediated calcium sensitization in serotonin-evoked vasoconstriction of rat cerebral arteries.

Authors:  Ahmed F El-Yazbi; Rosalyn P Johnson; Emma J Walsh; Kosuke Takeya; Michael P Walsh; William C Cole
Journal:  J Physiol       Date:  2010-03-29       Impact factor: 5.182

6.  Myosin phosphatase target subunit 1 (MYPT1) regulates the contraction and relaxation of vascular smooth muscle and maintains blood pressure.

Authors:  Yan-Ning Qiao; Wei-Qi He; Cai-Ping Chen; Cheng-Hai Zhang; Wei Zhao; Pei Wang; Lin Zhang; Yan-Ze Wu; Xiao Yang; Ya-Jing Peng; Ji-Min Gao; Kristine E Kamm; James T Stull; Min-Sheng Zhu
Journal:  J Biol Chem       Date:  2014-06-20       Impact factor: 5.157

7.  Myosin light chain kinase is necessary for tonic airway smooth muscle contraction.

Authors:  Wen-Cheng Zhang; Ya-Jing Peng; Gen-Sheng Zhang; Wei-Qi He; Yan-Ning Qiao; Ying-Ying Dong; Yun-Qian Gao; Chen Chen; Cheng-Hai Zhang; Wen Li; Hua-Hao Shen; Wen Ning; Kristine E Kamm; James T Stull; Xiang Gao; Min-Sheng Zhu
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

8.  Altered contractile phenotypes of intestinal smooth muscle in mice deficient in myosin phosphatase target subunit 1.

Authors:  Wei-Qi He; Yan-Ning Qiao; Ya-Jing Peng; Juan-Min Zha; Cheng-Hai Zhang; Chen Chen; Cai-Ping Chen; Pei Wang; Xiao Yang; Chao-Jun Li; Kristine E Kamm; James T Stull; Min-Sheng Zhu
Journal:  Gastroenterology       Date:  2013-03-13       Impact factor: 22.682

9.  Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.

Authors:  Claudia Mera; Iván Godoy; Renato Ramírez; Jackeline Moya; María Paz Ocaranza; Jorge E Jalil
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-10-21

10.  Ca2+ sensitization pathways accessed by cholinergic neurotransmission in the murine gastric fundus.

Authors:  Bhupal P Bhetwal; Kenton M Sanders; Changlong An; Danielle M Trappanese; Robert S Moreland; Brian A Perrino
Journal:  J Physiol       Date:  2013-04-22       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.